Evaluating the role of interleukin-2 and interleukin-12 in pediatric patients with concurrent Mycoplasma pneumoniae and Epstein-Barr virus infections

Table 2 Comparison of general data between poor prognosis group and non-poor prognosis group

Group	n	Age	Male/female	CRP in mg/L	Fever in days
Poor prognosis	56	5.31 ± 2.19	32/24	36.36 ± 9.09f	9.73 ± 2.84f
Non-poor prognosis	109	5.16 ± 2.56	61/48	29.16 ± 7.31	5.83 ± 1.84
t/χ2	-	0.231	0.684	2.546	3.858
P value	-	0.865	0.076	< 0.001	< 0.001

^fP < 0.001 vs non-poor prognosis group. CRP: C-reactive protein.